» Articles » PMID: 15449943

Structures of the Escherichia Coli PutA Proline Dehydrogenase Domain in Complex with Competitive Inhibitors

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2004 Sep 29
PMID 15449943
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Proline dehydrogenase (PRODH) catalyzes the first step of proline catabolism, the flavin-dependent oxidation of proline to Delta(1)-pyrroline-5-carboxylate. Here we present a structure-based study of the PRODH active site of the multifunctional Escherichia coli proline utilization A (PutA) protein using X-ray crystallography, enzyme kinetic measurements, and site-directed mutagenesis. Structures of the PutA PRODH domain complexed with competitive inhibitors acetate (K(i) = 30 mM), L-lactate (K(i) = 1 mM), and L-tetrahydro-2-furoic acid (L-THFA, K(i) = 0.2 mM) have been determined to high-resolution limits of 2.1-2.0 A. The discovery of acetate as a competitive inhibitor suggests that the carboxyl is the minimum functional group recognized by the active site, and the structures show how the enzyme exploits hydrogen-bonding and nonpolar interactions to optimize affinity for the substrate. The PRODH/L-THFA complex is the first structure of PRODH with a five-membered ring proline analogue bound in the active site and thus provides new insights into substrate recognition and the catalytic mechanism. The ring of L-THFA is nearly parallel to the middle ring of the FAD isoalloxazine, with the inhibitor C5 atom 3.3 A from the FAD N5. This geometry suggests direct hydride transfer as a plausible mechanism. Mutation of conserved active site residue Leu432 to Pro caused a 5-fold decrease in k(cat) and a severe loss in thermostability. These changes are consistent with the location of Leu432 in the hydrophobic core near residues that directly contact FAD. Our results suggest that the molecular basis for increased plasma proline levels in schizophrenic subjects carrying the missense mutation L441P is due to decreased stability of human PRODH2.

Citing Articles

Biochemical, structural, and cellular characterization of S-but-3-yn-2-ylglycine as a mechanism-based covalent inactivator of the flavoenzyme proline dehydrogenase.

Meeks K, Ji J, Scott G, Campbell A, Nix J, Tadeo A Arch Biochem Biophys. 2025; 765:110319.

PMID: 39870289 PMC: 11831987. DOI: 10.1016/j.abb.2025.110319.


Computational insights on the hydride and proton transfer mechanisms of L-proline dehydrogenase.

Yildiz I PLoS One. 2023; 18(11):e0290901.

PMID: 37967056 PMC: 10651016. DOI: 10.1371/journal.pone.0290901.


Structure-based engineering of minimal proline dehydrogenase domains for inhibitor discovery.

Bogner A, Ji J, Tanner J Protein Eng Des Sel. 2022; 35.

PMID: 36448708 PMC: 9801229. DOI: 10.1093/protein/gzac016.


Tea polyphenol epigallocatechin-3-gallate inhibits cell proliferation in a patient-derived triple-negative breast cancer xenograft mouse model via inhibition of proline-dehydrogenase-induced effects.

Lee W, Cheng T, Yen Y, Fang C, Liao Y, Kuo C J Food Drug Anal. 2022; 29(1):113-127.

PMID: 35696218 PMC: 9261841. DOI: 10.38212/2224-6614.3230.


Proline Dehydrogenase/Proline Oxidase (PRODH/POX) Is Involved in the Mechanism of Metformin-Induced Apoptosis in C32 Melanoma Cell Line.

Oscilowska I, Rolkowski K, Baszanowska W, Huynh T, Lewoniewska S, Niziol M Int J Mol Sci. 2022; 23(4).

PMID: 35216470 PMC: 8876342. DOI: 10.3390/ijms23042354.


References
1.
Guenther B, Sheppard C, Tran P, Rozen R, Matthews R, Ludwig M . The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol. 1999; 6(4):359-65. DOI: 10.1038/7594. View

2.
Sobolev V, Sorokine A, Prilusky J, Abola E, Edelman M . Automated analysis of interatomic contacts in proteins. Bioinformatics. 1999; 15(4):327-32. DOI: 10.1093/bioinformatics/15.4.327. View

3.
Surber M, Maloy S . Regulation of flavin dehydrogenase compartmentalization: requirements for PutA-membrane association in Salmonella typhimurium. Biochim Biophys Acta. 1999; 1421(1):5-18. DOI: 10.1016/s0005-2736(99)00104-2. View

4.
Fraaije M, Mattevi A . Flavoenzymes: diverse catalysts with recurrent features. Trends Biochem Sci. 2000; 25(3):126-32. DOI: 10.1016/s0968-0004(99)01533-9. View

5.
Maxwell S, Davis G . Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc Natl Acad Sci U S A. 2000; 97(24):13009-14. PMC: 27169. DOI: 10.1073/pnas.230445997. View